Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04089982 · ClinicalTrials.gov registry record · Phase 4
Varenicline Light Smoking Pilot
A Phase 4 study, sponsored by Duke University.
- Completed
- Registry status
- Phase 4
- Development phase
- 11
- Enrollment target
NCT04089982 is a Phase 4 study that has completed, run by Duke University. The registered enrollment target is 11 participants.
The verdict
NCT04089982, a Phase 4 study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 11 participants
- Enrollment target
Study Summary
The goal of this study is to assess varenicline vs. placebo for its effect on decreasing cue reactivity in light and intermittent smokers.
Interventions
- DRUG Varenicline
- DRUG Placebo oral tablet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2019-11-04 |
| Est. Completion | 2020-03-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04089982
The ClinicalTrials.gov registry entry for NCT04089982 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Varenicline is the first listed.
NCT04089982 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04089982 about?
NCT04089982 is a clinical study titled "Varenicline Light Smoking Pilot". The goal of this study is to assess varenicline vs. placebo for its effect on decreasing cue reactivity in light and intermittent smokers.
What is the current status of trial NCT04089982?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 11 participants. The study started on 2019-11-04. Estimated completion is 2020-03-01.
What interventions are being tested in trial NCT04089982?
The interventions under investigation include: Varenicline (DRUG), Placebo oral tablet (DRUG).
Who is sponsoring clinical trial NCT04089982?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.